In the News
Updated guideline released on PAD diagnosis and management
An updated guideline on diagnosis and management of peripheral artery disease was released last week by the American College of Cardiology Foundation and the American Heart Association, in conjunction with several other medical organizations.
Saw palmetto doesn't ease lower urinary tract symptoms in men
Saw palmetto extract, even up to three times the standard daily dose, had no more effect on lower urinary tract symptoms in men than placebo, a study found.
MKSAP Quiz: establish care for diabetes and hypertension
This week's quiz asks readers to evaluate a 60-year-old man with type 2 diabetes mellitus and hypertension who seeks to establish medical care.
SSRI increases bleeding risk after MI
Patients who received a selective serotonin reuptake inhibitor after acute myocardial infarction were at higher risk of bleeding, a study found.
Statins worked even for MI patients with low LDL
Statin therapy was beneficial for post-myocardial infarction patients who had low-density lipoprotein cholesterol levels under 70, a study found.
MRIs safe for ICDs and pacemakers, if proper protocol followed
Magnetic resonance imaging can be performed safely in patients with certain pacemakers and implantable cardioverter-defibrillators as long as expert staff are on hand to monitor and intervene if needed, a study found.
Isolated diastolic hypotension a risk factor for heart failure
Isolated diastolic hypotension is an independent risk factor for heart failure similar in magnitude to isolated systolic hypertension, researchers reported.
The next issue of ACP Internist is online and coming to your mailbox
October's issue of ACP Internist features stories on internists for pro sports teams, cardiovascular disease in the elderly and teaching medicine to Iraqi physicians, among others.
Put words in our mouth
ACP InternistWeekly wants readers to create captions for our new cartoon and help choose the winner. Pen the winning caption and win a $50 gift certificate good toward any ACP product, program or service.